© Copyright 2025 American Medical Association. All rights reserved.
| Short Descr | NEURO ALYS β-AMYL 1-42&1-40 | Medium Descr | NEURO MLD COG IMPAIRMNT ALYS β-AMYLOID 1-42&1-40 | Long Descr | Neurology (mild cognitive impairment), analysis of β-amyloid 1-42 and 1-40, chemiluminescence enzyme immunoassay, cerebral spinal fluid, reported as positive, likely positive, or negative | CLIA Waived (QW) | No | APC Status Indicator | Conditionally packaged laboratory tests | Berenson-Eggers TOS (BETOS) | none | MUE | 1 |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2024-01-01 | Added | First appearance of addition in codebook. |
| 2023-01-01 | Added | Code added. |
Get instant expert-level medical coding assistance.